Abstract

In vertebrates, the octopeptide angiotensin II (AngII) is an important in vivo regulator of the cardiovascular system. It acts mainly through two G protein-coupled receptors, AT1 and AT2. To better understand distinctive features of these receptors, we carried out a phylogenetic analysis that revealed a mirror evolution of AT1 and AT2, each one split into two clades, separating fish from terrestrial receptors. It also revealed that hallmark mutations occurred at, or near, the sodium binding site in both AT1 and AT2. Electrostatics computations and molecular dynamics simulations support maintained sodium binding to human AT1 with slow ingress from the extracellular side and an electrostatic component of the binding free energy around -3kT, to be compared to around -2kT for human AT2 and the δ opioid receptor. Comparison of the sodium binding modes in wild type and mutated AT1 and AT2 from humans and eels indicates that the allosteric control by sodium in both AT1 and AT2 evolved during the transition from fish to amniota. The unusual S7.46N mutation in AT1 is mirrored by a L3.36M mutation in AT2. In the presence of sodium, the N7.46 pattern in amniota AT1 stabilizes the inward orientation of N3.35 in the apo receptor, which should contribute to efficient N3.35 driven biased signaling. The M3.36 pattern in amniota AT2 favours the outward orientation of N3.35 and the receptor promiscuity. Both mutations have physiological consequences for the regulation of the renin-angiotensin system.

Highlights

  • The renin-angiotensin system (RAS) is an important in vivo regulator of multiple cardiovascular and renal functions in vertebrates [1–3]

  • We analyze the evolution of two G protein-coupled receptors, AT1 and AT2, which bind the angiotensin II peptide and are important regulators of the cardiovascular system

  • We show that these receptors underwent a mirror evolution

Read more

Summary

Introduction

The renin-angiotensin system (RAS) is an important in vivo regulator of multiple cardiovascular and renal functions in vertebrates [1–3]. It initiates with the cleavage of the angiotensinogen by renin into the decapeptide angiotensin I that is cleaved by the angiotensin converting enzyme 1 (ACE1) into the octapeptide angiotensin II (AngII). In the “classical” axis, AngII binds the type 1 AngII receptor (AT1) to induce most known effects of AngII, including vasoconstriction and increased blood pressure, anti-natriuresis, hypertrophy, fibrosis and inflammation [4,5]. Dysregulation of this axis promotes cardiac and vascular damages and AT1 blockers are widely used to fight hypertension. These receptors promote vasodilation, natriuresis, anti-inflammation, anti-fibrosis, and anti-proliferative responses that counterbalance AT1 effects [3,6,7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call